|
|
|
Volumn 10, Issue SUPPL. 2, 2003, Pages
|
|
Socratic dialogue: The future management of hyperlipidaemia
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTILIPEMIC AGENT;
ATENOLOL;
ATORVASTATIN;
BENDROFLUMETHIAZIDE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BISOPROLOL;
CHOLESTEROL;
COLESTYRAMINE;
CREATINE KINASE MB;
FENOFIBRATE;
FIBRIC ACID DERIVATIVE;
FISH OIL;
GEMFIBROZIL;
GLICLAZIDE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LIPID;
LISINOPRIL;
METFORMIN;
METOPROLOL;
MEVINOLIN;
OMEGA 3 FATTY ACID;
PRAVASTATIN;
RAMIPRIL;
SIMVASTATIN;
ANTIARRHYTHMIC ACTIVITY;
BLOOD PRESSURE REGULATION;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CASE STUDY;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
CONFERENCE PAPER;
DIABETES MELLITUS;
DIET THERAPY;
DRUG HYPERSENSITIVITY;
EVIDENCE BASED MEDICINE;
EXERCISE;
FAMILIAL HYPERCHOLESTEROLEMIA;
FAMILY HISTORY;
FISH;
GASTROINTESTINAL SYMPTOM;
GOOD CLINICAL PRACTICE;
HEALTH CARE;
HEALTH EDUCATION;
HEART INFARCTION;
HEART REHABILITATION;
HOSPITAL DISCHARGE;
HUMAN;
HYPERLIPIDEMIA;
ISCHEMIC HEART DISEASE;
LIFESTYLE;
LIPID BLOOD LEVEL;
LONG TERM CARE;
MEDICAL ASSESSMENT;
MEDICAL ETHICS;
METABOLIC DISORDER;
MUSCLE WEAKNESS;
MYALGIA;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PATIENT ATTITUDE;
PATIENT COMPLIANCE;
POLYPHARMACY;
PRACTICE GUIDELINE;
RISK ASSESSMENT;
SIDE EFFECT;
SMOKING;
TREATMENT PLANNING;
|
|
EID: 0043196701
PISSN: 09696113
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (6)
|
